Jean-Pierre Issa
Medical Oncology
Credentials: · · · ·
History
Medical Oncology
Internal Medicine
Research
CpG island methylator phenotype in colorectal cancer
Proceedings of the National Academy of Sciences of the United States of America · 1999 · Last of 6 authors · 2,017 citations
Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma
Proceedings of the National Academy of Sciences of the United States of America · 1998 · 1,629 citations
Alterations in DNA methylation: a fundamental aspect of neoplasia
Review · Advances in cancer research · 1998 · Last of 5 authors · 1,616 citations
59 papers
36 papers
- SH
23 papers
20 papers
19 papers · 12 as a resident
- SO
17 papers
16 papers
14 papers · 12 as a resident
Grants
- 2018–2028
TUFCCC/HC Regional Comprehensive Cancer Health Partnership
National Cancer Institute · U54
PI · $8.3M · Temple Univ of the Commonwealth
- 2021–2027
Epigenetic Therapies - New Approaches
National Cancer Institute · P50
Contact PI · $11.9M · Coriell Institute for Medical Research
- 2003–2024
SPORE University of Texas M. D. Anderson Cancer Center-Leukemia
National Cancer Institute · P50
Contact PI · $19M · University of Tx Md Anderson Can Ctr
- 2018–2024
TUFCCC/HC Regional Comprehensive Cancer Health Partnership
National Cancer Institute · U54
PI · $5.2M · Hunter College
Clinical trials
- 2006
Principal investigator · Completed · Phase 1
National Cancer Institute (NCI)
- 2005–2009
Principal investigator · Completed · Phase 1, Phase 2
M.D. Anderson Cancer Center
- 2003
Imatinib Mesylate and Decitabine in Treating Patients With Chronic Myelogenous Leukemia
Principal investigator · Completed · Phase 2
National Cancer Institute (NCI)
- 2005
Study chair · Completed · Phase 1
National Cancer Institute (NCI)